Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Moderna Inc
(NQ:
MRNA
)
122.88
-2.72 (-2.16%)
Streaming Delayed Price
Updated: 12:54 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Moderna Inc
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
99
100
Next >
Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion
October 16, 2023
Pfizer cut about $9 billion from its sales expectations for Covid products this year.
Via
Investor's Business Daily
Exposures
COVID-19
Novavax Faces Setback, European Authority Delays Decision On Variant-Tailored COVID-19 Vaccine
October 16, 2023
Novavax Inc (NASDAQ: NVAX) faces a setback as the European Medicines Agency (EMA) delays a decision on its variant-tailored COVID-19 vaccine.
Via
Benzinga
Exposures
COVID-19
The 10 Most Shorted Stocks Include 3 Tesla Rivals, But Not TSLA
October 16, 2023
Some big 2023 winners are shorted heavily, including two AI plays.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioNTech, Moderna And Other Big Stocks Moving Lower In Monday's Pre-Market Session
October 16, 2023
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Moderna Unusual Options Activity For October 12
October 12, 2023
Via
Benzinga
2 Top Biotech Stocks to Buy Right Now
October 12, 2023
Both companies are known innovators.
Via
The Motley Fool
These 2 Top Stocks Are Screaming Buys Right Now
October 07, 2023
These stocks are dirt cheap today.
Via
The Motley Fool
Can Moderna Achieve Its Most Ambitious Goal Yet?
October 05, 2023
Even the best of news has failed to boost Moderna shares in recent times.
Via
The Motley Fool
Is Novavax Stock a Buy Now?
October 16, 2023
Is this company just a pandemic stock?
Via
The Motley Fool
Don’t Hold On: 7 Stocks to Sell Before 2024
October 15, 2023
Consider it best to jettison these seven stocks to sell from your portfolio, between now and the end of 2023.
Via
InvestorPlace
1 Artificial Intelligence Stock to Buy Hand Over Fist in October and 1 to Avoid
October 13, 2023
One of these players could win in AI -- and in the healthcare market, in general.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Stocks That Are Down Big, But Are Due to Fall Much Further
October 12, 2023
While the search for falling stocks is an easy one, these are the ones that might not get up from the mat.
Via
InvestorPlace
The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments?
October 11, 2023
Vaccine revenue may have slipped but could still represent billions of dollars for these companies.
Via
The Motley Fool
Exposures
COVID-19
Big Pharma Could Transform Into BioTech Pharma
October 10, 2023
As the word itself says, biotechnology is simply technology based on biology. It uses the knowledge of cellular and biomolecular processes to develop technologies that improve our lives and overall...
Via
Benzinga
3 Shaky Stocks to Sell in October Before It’s Too Late
October 09, 2023
Investors who are concerned about the direction of the market moving forward should sell these three vulnerable stocks now.
Via
InvestorPlace
Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand
October 09, 2023
Last week, Novavax Inc (NASDAQ: NVAX) received FDA authorization for its updated COVID-19 vaccine, targeting the omicron subvariant XBB.1.5 in
Via
Benzinga
Exposures
COVID-19
Product Safety
Privatized Vaccine Distribution Sparks Confusion, Payment Challenges
October 09, 2023
As the rollout of the updated COVID-19 vaccine progresses, some individuals have been surprised by requests for upfront payments ranging from $150 to $200.
Via
Benzinga
Exposures
COVID-19
Intuit, Nordstrom And 2 Other Stocks Insiders Are Selling
October 09, 2023
The Nasdaq 100 closed higher by around 250 points on Friday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
3 Pharma Stocks to Dump Before the Damage Is Done
October 08, 2023
There's never a shortage of pharma stocks to sell due to the nature of the sector, especially when compounded by current fears.
Via
InvestorPlace
Rockwell’s Heitkoetter Talks Options Strategies, “Wheel Options,” Volatility, & Value Stocks
October 07, 2023
In this video, Markus Heitkoetter, CEO of Rockwell Trading Services, explains how he began investing as a high schooler with one share of Volkswagen.
Via
Talk Markets
Rule Breaker Investing's "Market Cap Game Show" Rolls On
October 07, 2023
This episode required a tiebreaker.
Via
The Motley Fool
This Could be Novavax's Big Opportunity
October 07, 2023
Novavax has lagged behind bigger rivals in the vaccine market.
Via
The Motley Fool
Did Moderna Just Jump Ahead of Rivals in a Potential Billion-Dollar Market?
October 06, 2023
Moderna, Pfizer, and Novavax all are working on combined vaccine candidates.
Via
The Motley Fool
Small Biotech Promosome Drops Lawsuit Against Pfizer, BioNTech in COVID-19 Vaccine Patent Dispute
October 05, 2023
Biotech firm Promosome has agreed to end the lawsuit, which accused the COVID-19 vaccine manufacturers, Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX), of patent infrin
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
COVID-19
Financial
Intellectual Property
Thinking Of Buying Alexandria Real Estate Equities? Here Are The Properties And Tenants You'd Add To Your Portfolio
October 05, 2023
Via
Benzinga
Why Novavax Stock Fell Today
October 04, 2023
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower Wednesday amid a pullback in the stock, which gained Tuesday after the FDA granted Emergency Use Authorization for the company's updated...
Via
Benzinga
Exposures
COVID-19
Product Safety
Mainz Biomed Continues To Transform Early Cancer Detection Across The Globe
October 04, 2023
While Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) are making great progress in cancer treatments, the importance of early detection in combating this disease cannot be overstated.
Via
Benzinga
Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares
October 04, 2023
3D Medicines Inc. was trading 7.2% higher in the Hong Kong Wednesday morning session at HK$5.53 after the company announced that it is buying back up to 10% of its own stock.
Via
Benzinga
Short Sellers Are Betting Against Novavax (NVAX) Stock
October 04, 2023
Shorts are betting no one will want Novavax's Covid-19 vaccine, but the pandemic is not yet over, and NVAX stock is cheap.
Via
InvestorPlace
Exposures
COVID-19
What's Going On With Moderna Stock Wednesday?
October 04, 2023
Moderna, Inc (NASDAQ: MRNA) shares are trading higher Wednesday.
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.